Author of the publication

Serum glutamic acid decarboxylase 65 antibody levels in people with schizophrenia and their families.

, , , and . Schizophrenia research, 73 (2-3): 379--381 (March 2005)
DOI: 10.1016/j.schres.2004.05.004

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Classification of schizophrenic patients and healthy controls using 18F fluorodopa PET imaging., , , , , , and . Schizophrenia research, 106 (2-3): 148--155 (December 2008)The effect of clozapine on factors controlling glucose homeostasis., , , , and . The Journal of clinical psychiatry, 65 (10): 1352--1355 (October 2004)Pathways to schizophrenia: the impact of environmental factors., , , , , and . The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), (March 2004)The relationship between prolactin levels and glucose homeostasis in antipsychotic-treated schizophrenic patients., , , , , and . Journal of clinical psychopharmacology, 26 (6): 629--631 (December 2006)Serum glutamic acid decarboxylase 65 antibody levels in people with schizophrenia and their families., , , and . Schizophrenia research, 73 (2-3): 379--381 (March 2005)Functional neuroimaging in schizophrenia: diagnosis and drug discovery., , , and . Trends in pharmacological sciences, 29 (2): 91--98 (February 2008)The dopamine hypothesis of schizophrenia: version III--the final common pathway., and . Schizophrenia bulletin, 35 (3): 549--562 (May 2009)Elevated striatal dopamine function linked to prodromal signs of schizophrenia., , , , , , , , , and 2 other author(s). Archives of general psychiatry, 66 (1): 13--20 (January 2009)A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance., , , , , and . The American journal of psychiatry, 161 (2): 361--363 (February 2004)Understanding pathophysiology is crucial in linking clinical staging to targeted thera-peutics., , and . World psychiatry : official journal of the World Psychiatric Association (WPA), 7 (3): 162--163 (October 2008)